Novel Inhibitors of T315I Mutant BCR-ABL1 Tyrosine Kinase for Chronic Myeloid Leukemia Disease Through Fragment-Based Drug Design.
Satya AninditaAtika MarnoliaHersal Hermana PutraMuhammad Chandra HaikalUsman Sumo Friend TambunanPublished in: ISBRA (2018)
Keyphrases
- drug design
- protein protein interactions
- functional genomics
- biological data
- microarray data
- dna microarray
- molecular biology
- high throughput
- chronic disease
- gene expression data
- gene sets
- data analysis
- protein structure prediction
- systems biology
- quantitative structure activity
- gene ontology
- microarray
- gene selection
- gene regulatory networks
- sequence alignment
- gene expression
- biological networks
- data sets
- computational methods
- functional modules
- statistical methods
- drug discovery
- genome wide
- network analysis
- cluster analysis
- health care
- social network analysis
- feature selection